Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD 0299685 in Interstitial Cystitis/Painful Bladder Syndrome
NCT00739739Phase 2Completed
- Sponsor
- Pfizer
- Start
- Aug 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial of PD-0299685 in interstitial cystitis (IC) (3 arms), sponsored by Pfizer. Primary endpoints: O'Leary-Sant Interstitial Cystitis Symptom Index at 12 weeks and Worst Daily Pain Severity Score at 12 weeks. Started Aug 2008; status: completed.
02
Drugs
PD-0299685
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT00739739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00739739.